Branton et al., 2017 - Google Patents
Evaluation of the effect of the energy of consciousness healing treatment on physicochemical and thermal properties of pyridoxine hydrochlorideBranton et al., 2017
View PDF- Document ID
- 9490273359136105784
- Author
- Branton A
- Jana S
- Publication year
- Publication venue
- American Journal of Physical Chemistry
External Links
Snippet
Pyridoxine hydrochloride is water-soluble B vitamin widely used for the prevention and treatment of vitamin B6 deficiency and other several diseases. The aim of this study was to explore the effect of The Trivedi Effect®-Energy of Consciousness Healing Treatment on the …
- 235000019171 pyridoxine hydrochloride 0 title abstract description 61
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Trivedi et al. | A Systematic study of the biofield energy healing treatment on physicochemical, thermal, structural, and behavioral properties of magnesium gluconate | |
Al-Hamidi et al. | Effect of glucosamine HCl on dissolution and solid state behaviours of piroxicam upon milling | |
Trivedi et al. | Evaluation of the impact of biofield energy healing treatment (the trivedi effect®) on the physicochemical, thermal, structural, and behavioral properties of magnesium gluconate | |
Nayak et al. | Evaluation of the effect of consciousness energy healing treatment on the physicochemical and thermal properties of selenium | |
Trivedi et al. | Evaluation of the physicochemical, spectral, thermal and behavioral properties of sodium selenate: influence of the energy of consciousness healing treatment | |
Trivedi et al. | A comprehensive analytical evaluation of the Trivedi Effect®-Energy of Consciousness Healing Treatment on the physical, structural, and thermal properties of zinc chloride | |
Trivedi et al. | Effect of consciousness energy healing treatment on the metal profile and properties of tellurium | |
Branton et al. | Evaluation of the effect of the energy of consciousness healing treatment on physicochemical and thermal properties of pyridoxine hydrochloride | |
Agarwal et al. | In-silico validation and development of chlorogenic acid (CGA) loaded polymeric nanoparticle for targeting neurodegenerative disorders | |
Nayak et al. | The energy of consciousness healing treatment: Impact on physicochemical and thermal properties of l-tryptophan | |
Branton et al. | A Study on the Effect of the Energy of Consciousness Healing Treatment on Physicochemical and Thermal Properties of Vitamin D 3 (Cholecalciferol) | |
Trivedi et al. | Study of the energy of consciousness healing treatment on physical, structural, thermal, and behavioral properties of zinc chloride | |
Trivedi et al. | Characterization of physical, structural, thermal, and behavioral properties of the consciousness healing treated zinc chloride | |
Trivedi et al. | An Impact of energy of consciousness (The Trivedi Effect®) on the physicochemical, thermal, structural, and behavioral properties of magnesium gluconate | |
Branton et al. | Characterization of physicochemical and thermal properties of energy of consciousness healing treated copper (II) chloride using PXRD, DSC, and TGA/DTG | |
Trivedi et al. | Effect of the Consciousness Energy Healing Treatment: Characterization of the Physicochemical and Thermal Properties of Vitamin B6 | |
Trivedi et al. | Evaluation of consciousness energy healing treated pyridoxine (vitamin B6) | |
Trivedi et al. | Consciousness energy healing treatment: Impact on physicochemical and thermal properties of zinc | |
Branton et al. | Assessment of physicochemical and thermal properties of energy of consciousness healing treated ferrous sulphate using PXRD, PSD, DSC, and TGA/DTG Analysis | |
Branton et al. | Impact of consciousness energy healing treatment on the physicochemical and thermal properties of magnesium gluconate | |
Trivedi et al. | Solid State Characterization of Consciousness Energy Healing Treated Magnesium Gluconate using PXRD, PSA, DSC and TGA/DTG Analysis | |
Trivedi et al. | Characterization of the Physicochemical, Structural, and Thermal Properties of Zinc Chloride After the Consciousness Energy Healing Treatment | |
Trivedi et al. | Physicochemical and thermal analysis of the consciousness energy healing treated ofloxacin | |
Trivedi et al. | Particle Size, Surface Area, Crystallite Size, and Thermal Analysis of Consciousness Energy Healing Treated Selenium | |
Trivedi et al. | Physical, Thermal, and Spectroscopic Characterization of the Biofield Energy Treated Pyridoxine Hydrochloride |